Aspirin protects against heart disease, while COX-2 Inhibitors appear to injure the heart. The studies by Francois et al. (2005 [this Issue of Cell Metabolism]) shed light on two distinct prostaglandin receptors contributing to these conflicting cardiovascular effects
Cyclooxygenase (COX)-1 and COX-2 are centrally important enzymes within the cardiovascular system wi...
Since their approval in 1998, the popularity of selective cyclooxygenase-2 (COX2) inhibitors has swu...
coxibs, were developed to inhibit inflammatory prostaglandins derived from COX-2, while sparing gast...
Aspirin protects against heart disease, while COX-2 Inhibitors appear to injure the heart. The studi...
AbstractNonsteroidal anti-inflammatory drugs (NSAID) inhibit cyclooxygenase (COX) enzymes, which exi...
Aspirin has been a commercial drug for over a century, although for most of this history, an under-s...
Grosser T, Fries S, FitzGerald GA. Biological basis for the cardiovascular consequences of COX-2 in...
AbstractThis report confirms evidence that selective nonsteroidal anti-inflammatory drugs (NSAIDs), ...
Selective inhibitors of cyclooxygenase- 2 ( COX- 2, ` coxibs') are highly effective anti-inflammator...
Fries S, Grosser T. The cardiovascular pharmacology of COX-2 inhibition. Hematology Am Soc Hematol E...
Aspirin has been a commercial drug for over a century, although for most of this history, an underst...
Aspirin has been a commercial drug for over a century, although for most of this history, an underst...
Cheng Y, Austin SC, Rocca B, et al. Role of Prostacyclin in the Cardiovascular Response to Thromboxa...
The use of daily aspirin has been proven to be effectivein the primary and secondary prevention of c...
Inhibition of cyclo-oxygenase (COX)-2 by nonsteroidal anti-inflammatory drugs (NSAIDs), including CO...
Cyclooxygenase (COX)-1 and COX-2 are centrally important enzymes within the cardiovascular system wi...
Since their approval in 1998, the popularity of selective cyclooxygenase-2 (COX2) inhibitors has swu...
coxibs, were developed to inhibit inflammatory prostaglandins derived from COX-2, while sparing gast...
Aspirin protects against heart disease, while COX-2 Inhibitors appear to injure the heart. The studi...
AbstractNonsteroidal anti-inflammatory drugs (NSAID) inhibit cyclooxygenase (COX) enzymes, which exi...
Aspirin has been a commercial drug for over a century, although for most of this history, an under-s...
Grosser T, Fries S, FitzGerald GA. Biological basis for the cardiovascular consequences of COX-2 in...
AbstractThis report confirms evidence that selective nonsteroidal anti-inflammatory drugs (NSAIDs), ...
Selective inhibitors of cyclooxygenase- 2 ( COX- 2, ` coxibs') are highly effective anti-inflammator...
Fries S, Grosser T. The cardiovascular pharmacology of COX-2 inhibition. Hematology Am Soc Hematol E...
Aspirin has been a commercial drug for over a century, although for most of this history, an underst...
Aspirin has been a commercial drug for over a century, although for most of this history, an underst...
Cheng Y, Austin SC, Rocca B, et al. Role of Prostacyclin in the Cardiovascular Response to Thromboxa...
The use of daily aspirin has been proven to be effectivein the primary and secondary prevention of c...
Inhibition of cyclo-oxygenase (COX)-2 by nonsteroidal anti-inflammatory drugs (NSAIDs), including CO...
Cyclooxygenase (COX)-1 and COX-2 are centrally important enzymes within the cardiovascular system wi...
Since their approval in 1998, the popularity of selective cyclooxygenase-2 (COX2) inhibitors has swu...
coxibs, were developed to inhibit inflammatory prostaglandins derived from COX-2, while sparing gast...
DOI
Add to ORKG